Johnson & Johnson to pay $55 million after it loses second ovarian cancer case!
Worldwide health care giant Johnson & Johnson (J&J) has lost the second case in a row in the last four months over charges of its popular talcum powder triggering ovarian cancer amongst females. In the fresh verdict on Monday, a U.S federal court directed J&J to pay $55 million to 62-year-old Gloria Ristesund, who had actually declared that she developed ovarian cancer using J&J talcum powder for feminine hygiene purposes.
J&J was asked in February by the exact same federal court to pay $72 million to the family of a female who had apparently died due to prolonged usage of the company’s talcum powder. The company is faced with yet another trial related to baby powder in the St Louis Court in September.
J&J is presently embroiled in more than 1,000 lawsuits in various U.S. courts where the company is charged of not alerting customers of the potential health threats of its talcum powder and Shower To Shower products.
“The more talc verdicts that boil down versus them adds to the public’s growing distrust of their baby powder, which is among their famous items,” stated Carl Tobias, an instructor of product-liability law at the University of Richmond in Virginia.
He stated J&J needs to think about international settlement of these cases to fix both financial and reputational issues that it is confronted with.
Ristesund, the new victim, was diagnosed with cancer in 2011 after using J&J’s talcum powder for almost 40 years. She went through hysterectomy, after which her cancer was said to be in remission.
“Science has actually been simple and consistent over the last 40 years. There is an increased danger of ovarian cancer from genital use of talc,” said Allen Smith, Ristesund’s legal representative to the jurors.
He even said Ristesund used talc for 4 decades without understanding that there were any health issues.
Meanwhile, J&J chose to appeal the verdict. The company defended the security of its items by saying the verdict was against the research study carried out by experts for last three decades which support the use of J&J baby powder as a cosmetic product.
“Regrettably, the jury’s decision goes against three decades of studies by medical professionals around the word that continue to support the safety of cosmetic talc,” J&J
spokeswoman Carol Goodrich said.
She added that J&J has constantly taken issues concerning the safety of its items seriously.
A U.S. federal court had in March asked J&J to pay $500 million to five clients who had alleged that they suffered from injuries after using the brand’s Peak metal-on-metal hip implants.